Clinical interpretation of integrative molecular profiles to guide precision cancer medicine
B. Reardon, N. D. Moore, N. Moore, E. Kofman, S. Aldubayan, A. Cheung, J. Conway, H. Elmarakeby, A. Imamovic, S. C. Kamran, T. Keenan, D. Keliher, D. J. Konieczkowski, D. Liu, K. Mouw, , E. M. Van Allen
This paper introduces MOAlmanac, a clinical interpretation algorithm that integrates genomic and transcriptional data to improve precision cancer treatment decisions by considering second-order molecular features.
bioRxiv · Sep 22, 2020Cancer Biology